{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:41:42Z","timestamp":1792446102141,"version":"4.5.0"},"reference-count":30,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We conducted a retrospective study to determine whether the presence of moyamoya collaterals influenced the risk of recurrence of cerebrovascular events (CVEs: stroke or transient ischemic attack) in patients with sickle cell disease placed on chronic transfusions after a stroke. Forty-three patients with homozygous sickle cell anemia (HbSS) and 1 with HbSOArab (16 females, 28 males) who had suffered strokes while under the age of 18 were studied. All patients had been on transfusions aimed at maintaining the sickle hemoglobin (HbS) level below 30%. They were followed for a mean of 6.6 years (2.2 to 20.4 years). The presence of collaterals was diagnosed based on either magnetic resonance angiography or conventional angiography. Eighteen (41%) of the 44 patients suffered recurrent CVEs. Nineteen (43%) (6 females, 13 males) patients had moyamoya collaterals. Eleven (58%) of these 19 experienced 21 total recurrent CVEs, including 4 strokes in 4 patients (21%). In comparison, 7 (28%) of 25 patients without moyamoya collaterals experienced 9 recurrent CVEs (P\u2009&amp;lt;\u2009.05) with only 1 recurrent stroke (4%). Moyamoya patients were also more likely to have 2 recurrent CVEs (42% vs 8%,P\u2009&amp;lt;\u2009.05) as well as poorer neuropsychological testing results. A proportional hazards regression analysis indicated that patients with moyamoya were more than twice as likely to incur a subsequent CVE (hazard ratio, 2.40; 95% confidence interval, 0.85, 6.75). We conclude that up to 41% of patients with sickle cell disease experience recurrent CVEs after an initial stroke despite chronic transfusions and that the risk of recurrence is significantly higher for those who have moyamoya collaterals.<\/jats:p>","DOI":"10.1182\/blood.v99.9.3144","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:33:52Z","timestamp":1034361232000},"page":"3144-3150","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":237,"title":["Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events"],"prefix":"10.1182","volume":"99","author":[{"given":"Scott R.","family":"Dobson","sequence":"first","affiliation":[{"name":"From the Departments of Neurology, Pediatrics, and Radiology and the Center for Health Care Research, Medical University of South Carolina, Charleston, SC; and the Department of Pediatrics, Medical College of Virginia, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenton R.","family":"Holden","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology, Pediatrics, and Radiology and the Center for Health Care Research, Medical University of South Carolina, Charleston, SC; and the Department of Pediatrics, Medical College of Virginia, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Nietert","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology, Pediatrics, and Radiology and the Center for Health Care Research, Medical University of South Carolina, Charleston, SC; and the Department of Pediatrics, Medical College of Virginia, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel K.","family":"Cure","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology, Pediatrics, and Radiology and the Center for Health Care Research, Medical University of South Carolina, Charleston, SC; and the Department of Pediatrics, Medical College of Virginia, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Laver","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology, Pediatrics, and Radiology and the Center for Health Care Research, Medical University of South Carolina, Charleston, SC; and the Department of Pediatrics, Medical College of Virginia, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Disco","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology, Pediatrics, and Radiology and the Center for Health Care Research, Medical University of South Carolina, Charleston, SC; and the Department of Pediatrics, Medical College of Virginia, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel R.","family":"Abboud","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology, Pediatrics, and Radiology and the Center for Health Care Research, Medical University of South Carolina, Charleston, SC; and the Department of Pediatrics, Medical College of Virginia, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222464313700_B1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00043426-198224000-00006","article-title":"Neurological complications of sickle cell anemia.","volume":"4","author":"Sarnaik","year":"1982","journal-title":"Pediatr Hematol Oncol."},{"key":"2020021222464313700_B2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9343(78)90772-6","article-title":"The natural history of stroke in sickle cell disease.","volume":"65","author":"Powars","year":"1978","journal-title":"Am J Med."},{"key":"2020021222464313700_B3","first-page":"101","article-title":"Strokes and their management in sickle cell disease.","volume-title":"Comparative Clinical Aspects of Sickle Cell Disease.","author":"Moohr","year":"1982"},{"key":"2020021222464313700_B4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3476(05)80897-2","article-title":"Stroke in a cohort of patients with homozygous sickle cell disease.","volume":"120","author":"Balkaran","year":"1992","journal-title":"J Pediatr."},{"key":"2020021222464313700_B5","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors.","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood."},{"key":"2020021222464313700_B6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-3101(24)00141-5","article-title":"Neurologic complications of sickle cell disease.","volume":"36","author":"Pavlakis","year":"1989","journal-title":"Adv Pediatr."},{"key":"2020021222464313700_B7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.38.7.1012","article-title":"Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI.","volume":"38","author":"Adams","year":"1988","journal-title":"Neurology."},{"key":"2020021222464313700_B8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJM197210262871703","article-title":"Occlusion of large cerebral vessels in sickle-cell anemia.","volume":"287","author":"Stockman","year":"1972","journal-title":"N Engl J Med."},{"key":"2020021222464313700_B9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00270916","article-title":"Moyamoya disease.","volume":"4","author":"Maki","year":"1988","journal-title":"Childs Nerv Syst."},{"key":"2020021222464313700_B10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.STR.14.1.104","article-title":"Moyamoya disease\u2014a review.","volume":"14","author":"Suzuki","year":"1983","journal-title":"Stroke."},{"key":"2020021222464313700_B11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-3101(24)00263-9","article-title":"Stroke in children.","volume":"38","author":"Pavlakis","year":"1991","journal-title":"Adv Pediatr."},{"key":"2020021222464313700_B12","first-page":"1254","article-title":"Periodic transfusions for sickle cell anemia and CNS infarction.","volume":"133","author":"Sarnaik","year":"1979","journal-title":"Am J Dis Child."},{"key":"2020021222464313700_B13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.","volume":"126","author":"Pegelow","year":"1995","journal-title":"J Pediatr."},{"key":"2020021222464313700_B14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3476(05)82150-X","article-title":"High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease.","volume":"118","author":"Wang","year":"1991","journal-title":"J Pediatr."},{"key":"2020021222464313700_B15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3476(83)80716-1","article-title":"Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia.","volume":"103","author":"Buchanan","year":"1983","journal-title":"J Pediatr."},{"key":"2020021222464313700_B16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/088307380001500504","article-title":"Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients.","volume":"15","author":"Chabrier","year":"2000","journal-title":"J Child Neurol."},{"key":"2020021222464313700_B17","first-page":"50","article-title":"Moyamoya disease: MRI and MR angiography.","volume":"33(suppl)","author":"Demaerel","year":"1991","journal-title":"Neuroradiology."},{"key":"2020021222464313700_B18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1148\/radiology.164.1.3588894","article-title":"Moyamoya disease: MR imaging.","volume":"164","author":"Fujisawa","year":"1987","journal-title":"Radiology."},{"key":"2020021222464313700_B19","first-page":"332a","article-title":"Neuropsychological functioning in children with sickle cell disease and stroke.","volume":"8","author":"Shimoda","year":"1994","journal-title":"Clin Neuropsychol [abstract]."},{"key":"2020021222464313700_B20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med."},{"key":"2020021222464313700_B21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V63.1.162.162","article-title":"Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease.","volume":"64","author":"Russell","year":"1984","journal-title":"Blood."},{"key":"2020021222464313700_B22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/oso\/9780195132892.001.0001","volume-title":"Ischemic Cerebrovascular Disease.","author":"Adams","year":"2001"},{"key":"2020021222464313700_B23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0022-3476(78)81086-5","article-title":"Moyamoya in children with sickle cell anemia and cerebrovascular occlusion.","volume":"92","author":"Seeler","year":"1978","journal-title":"J Pediatr."},{"key":"2020021222464313700_B24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/1531-8249(20010201)49:2<222::AID-ANA42>3.0.CO;2-S","article-title":"Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts.","volume":"49","author":"Steen","year":"2001","journal-title":"Ann Neurol."},{"key":"2020021222464313700_B25","first-page":"405","article-title":"Neurologic complications following bone marrow transplantation for sickle cell disease.","volume":"17","author":"Abboud","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"2020021222464313700_B26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3476(05)80687-0","article-title":"Diagnosis of cerebrovascular disease in sickle cell anemia by magnetic resonance angiography.","volume":"117","author":"Wiznitzer","year":"1990","journal-title":"J Pediatr."},{"key":"2020021222464313700_B27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1054\/jocn.1999.0160","article-title":"Comparative performance of magnetic resonance angiography and conventional angiography in moyamoya disease.","volume":"7","author":"Saeki","year":"2000","journal-title":"J Clin Neurosci."},{"key":"2020021222464313700_B28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00607263","article-title":"Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability.","volume":"38","author":"Kandeel","year":"1996","journal-title":"Neuroradiology."},{"key":"2020021222464313700_B29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.97","article-title":"Perfusion magnetic resonance abnormalities in patients with sickle cell disease.","volume":"49","author":"Kirkham","year":"2001","journal-title":"Ann Neurol."},{"key":"2020021222464313700_B30","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V94.9.3022","article-title":"Hydroxyurea as an alternative to blood transfusion for the prevention of recurrent stroke in children with sickle cell disease.","volume":"94","author":"Were","year":"1999","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/9\/3144\/1683034\/h80902003144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/9\/3144\/1683034\/h80902003144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T18:05:53Z","timestamp":1733767553000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/9\/3144\/54139\/Moyamoya-syndrome-in-childhood-sickle-cell-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.9.3144","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5,1]]}}}